Potential of magnetization transfer MRI for target volume definition in patients with non-small-cell lung cancer

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 6, 2008, Pages 1417-1424

  Arnold, Johannes F T ^a   Kotas, Markus ^a   Pyzalski, Robert W ^b   Pracht, Eberhard D ^a   Flentje, Michael ^a   Jakob, Peter M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

FDG PET; Magnetization transfer; Non small cell lung cancer; Radiotherapy planning; Target volume

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; ATELECTASIS; CANCER RADIOTHERAPY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT PLANNING;

ARTIFACTS; CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 57049171925     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21436     Document Type: Article

References (37)

1. Senan S, van Sornsen de Koste, Samson J, et al. Evaluation of target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol 1999;53:247-255.
2. Logue JP, Sharrock CL, Cowan RA, et al. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 1998;41:929-931.
3. Giraud P, Elles S, Helfre S, et al. Conformal radiotherapy for lung cancer: Different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 2002;62:27-36.
4. Van de Steene J, Linthout N, de Mey J, et al. Definition of gross tumor volume in lung cancer: Inter-observer variability. Radiother Oncol 2002;62:37-49.
5. Grills IS, Yan D, Martinez AA. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 2003;57:875-890.
6. Kiffer JD, Berlangieri SU, Scott AM, et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998;19:167-177.
7. Erdi YE, Rosenzweig K, Erki AK, et al. Defining a radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography. Radiother Oncol 2002;62:51-60.
8. De Ruysscher D, Wanders S, Minken A, et al. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study. Radiother Oncol 2005;77:5-10.
9. Ashamalla H, Rafla S, Parikh K, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 2005;63:1016-1023.
10. Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;59:78-86.
11. Nestle U, Kremp S, Grosu AL. Practical integration of [(18)F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006;81:209-225.
12. Van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 2006;32:245-260.
13. Nestle U, Walter K, Schmidt S, et al. 18F-deoxyglucose positron emission tomography (FDG-PET) fort he planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999;44:593-597.
14. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:134-144.
15. Horsfield. Magnetization transfer imaging in multiple sclerosis. J Neuroimaging 2005;15:58S-67S.
16. Henkelman RM, Stanisz GJ, Graham SJ. Magnetization transfer in MRI: a review. J NMR Biomed 2001;14:57-64.
17. Kuzo RS, Kormano MJ, Lipton MJ. Magnetization transfer magnetic resonance imaging of parenchymal lung disease. Invest Radiol 1995;30:118-122.
18. Henkelman RM, Huang X, Xiang QS, et al. Quantitative Interpretation of magnetization transfer. Magn Reson Med 1993;29:759-766.
19. Morrison C, Henkelman RM. A model for magnetization transfer in tissues. Magn Reson Med 1995;33:475-482.
20. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884.
21. Hatabu H, Gaa J, Tadamura E, et al. MR imaging of pulmonary parenchyma with a half-fourier single-shot turbo spin-echo (HASTE) sequence. Eur J Radiol 1999;29:152-159.
22. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35:2011-2018.
23. Dice LR, Measures of the amount of ecologic association between species. Ecology 1945;26:297-302.
24. Zijdenbos AP, Dawant BM, Margolin RA, et al. Morphometric analysis of white matter lesions in MR images: method and validation. IEEE Trans Med Imaging 1994;13:716-724.
25. Lavrenkov K, Partridge M, Cook, et al. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer. Radiother Oncol 2005;77:1-4.
26. Fralix TA, Ceckler TL, Wolff SD, et al. Lipid bilayer and water proton magnetization transfer: effect of cholesterol. Magn Reson Med 1991;18:214-223.
27. Koenig SH. Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain. Magn Reson Med 1991;20:285-291.
28. Ceckler TL, Wolff SD, Simon A, et al. Dynamic and chemical factors affecting water proton relaxation by macromolecules. J Magn Reson 1992;98:637-645.
29. Kurki T, Lundbom N, Kalimo H, et al. MR classification of brain gliomas: value of magnetization transfer and conventional imaging. Magn Reson Imaging 1995;13:501-511.
30. Pui MH. Magnetization transfer analysis of brain tumor, infection, and infarction. J Magn Reson Imaging 2000;12:395-399.
31. Takashima S, Takayama F, Wang Q, et al. Head and neck lesions: Determination of an optimal MT technique for prediction of malignancies. Invest Radiol 2000;35:244-252.
32. Li KCP, Hopkins KL, Moore SG, et al. Magnetization transfer contrast MRI of musculoskeletal neoplasms. Skeletal Radiol 1995;200:369-375.
33. Takashima S, Wang J, Takayama F, et al. Parotid masses: Prediction of malignancy using magnetization transfer and MR imaging findings. AJR Am J Roentgenol 2001;176:1577-1584.
34. Wolff SD, Balaban RS. Magnetization transfer imaging. Practical aspects and clinical applications. Radiology 1994;192:593-599.
35. Zou KH, Warfield SK, Bharatha A, Tempany CMC, Kaus MR, Haker SJ, Wells III WM, Jolesz FA, Kikinis R. Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol 2004;11:178-189.
36. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized auto-calibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47:1202-1210.
37. Pruessmann KP, Weiger M, Scheidegger MB, et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.